MarTech platform and services for pharma digital marketing and content distribution
Viseven operates a dual model: a SaaS platform (eWizard) for pharmaceutical content creation and omnichannel distribution, plus a 700+ person services organization delivering marketing transformation. The tech stack reveals a modern, AI-capable application layer (TypeScript/Node.js, Vue/React, LangChain/LangGraph) built for scale (Kubernetes, PostgreSQL, OpenSearch), but pain-point clustering around data integration, account revenue growth, and process inefficiency suggests the services tail is pulling engineering focus away from product infrastructure modernization.
Notable leadership hires: Account Director, Product Head
Viseven provides digital marketing solutions for pharmaceutical, life sciences, and healthcare companies. The core product, eWizard, is a content experience platform designed to streamline creation and multichannel distribution of pharma marketing materials. Beyond the platform, Viseven operates a global services practice spanning omnichannel marketing, eDetailing, design, digital transformation consulting, and app development. The company serves enterprise pharma clients and is actively scaling through strategic account expansion, new product launches, and organizational restructuring across Europe and North America.
TypeScript, Node.js, Vue, React, Python, LangChain/LangGraph for AI, Kubernetes, PostgreSQL, OpenSearch, and Adobe Creative Suite. Recently integrated Jira and Confluence for collaboration.
Poland, Romania, Bulgaria, Ukraine, and Italy. Active recruitment spans product, engineering, sales, and operations across these regions.
Viseven's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.